Fundraising Fox

Citius Pharmaceuticals

NASDAQ: CTXR

Cranford, US · Nevada corporation

Citius Pharmaceuticals is a late-stage biopharmaceutical company developing and commercializing critical care products, including anti-infectives, oncology and adjunct cancer care treatments, stem cell therapy, and prescription products.

BiotechHealthtech

Founders & leadership

LMLeonard Mazur
Leonard MazurFounder
MH
Myron HolubiakExecutive
JBJaime Bartushak
Jaime BartushakExecutive

Board

CW
Carol WebbBoard director
SD
Suren DutiaBoard director
WK
William KaneBoard director
HS
Howard SafirBoard director
EH
Eugene HolukaBoard director

Reported raises · per SEC filings

Form D private placements

$21.3M disclosed across 6 rounds · 2016–2021

▶$20MraisedFeb 2021 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Carol WebbDirector
  • Suren DutiaDirector
  • Leonard MazurExecutive Officer, Director
  • Myron HolubiakExecutive Officer, Director
  • Eugene HolukaDirector
  • Jaime BartushakExecutive Officer
  • William KaneDirector
  • Howard SafirDirector
Offering amount
$20M
Amount sold
$20M
Sales commissions
$1.4M
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jan 2021
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$220.6KraisedMay 2020 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Eugene HolukaDirector
  • Howard SafirDirector
  • Suren DutiaDirector
  • William KaneDirector
  • Carol WebbDirector
  • Jaime BartushakExecutive Officer
  • Myron HolubiakExecutive Officer, Director
  • Leonard MazurExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$220.6K
Sales commissions
$15.4K
Placement agents
H.C. Wainwright & Co., LLC
First sale
May 2020
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$428.8KraisedApr 2019 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Carol WebbDirector
  • Myron HolubiakExecutive Officer, Director
  • Leonard MazurExecutive Officer, Director
  • Suren DutiaDirector
  • Jaime BartushakExecutive Officer
  • William KaneDirector
  • Howard SafirDirector
  • Eugene HolukaDirector
Offering amount
$428.8K
Amount sold
$428.8K
Sales commissions
$30K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Apr 2019
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$83.7KraisedMay 2018 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Suren DutiaDirector
  • Howard SafirDirector
  • Myron HolubiakExecutive Officer, Director
  • Jaime BartushakExecutive Officer
  • Leonard MazurExecutive Officer, Director
  • Carol WebbDirector
  • Eugene HolukaDirector
  • William KaneDirector
Offering amount
$83.7K
Amount sold
$83.7K
Sales commissions
$5.9K
First sale
Mar 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40KraisedDec 2017 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Howard SafirDirector
  • Leonard MazurExecutive Officer, Director
  • Myron HolubiakExecutive Officer, Director
  • Suren DutiaDirector
  • Eugene HolukaDirector
  • Carol WebbDirector
  • William KaneDirector
  • Jaime BartushakExecutive Officer
Offering amount
$40K
Amount sold
$40K
Sales commissions
$2.8K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Dec 2017
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$549.9KraisedFeb 2017 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • William KaneDirector
  • Myron HolubiakExecutive Officer, Director
  • Howard SafirDirector
  • Eugene HolukaDirector
  • Carol WebbDirector
  • Leonard MazurExecutive Officer, Director
  • Suren DutiaDirector
Offering amount
$6M
Amount sold
$549.9K
Minimum investment
$50K
First sale
Nov 2016
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap
Robinhood34 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha29 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Public26 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.

Companies competing with Citius Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Citius Pharmaceuticals do?
Citius Pharmaceuticals is a late-stage biopharmaceutical company developing and commercializing critical care products, including anti-infectives, oncology and adjunct cancer care treatments, stem cell therapy, and prescription products.
Who founded Citius Pharmaceuticals?
Citius Pharmaceuticals was founded by Leonard Mazur.
How much funding has Citius Pharmaceuticals raised?
Citius Pharmaceuticals has disclosed $21.3M raised across 6 rounds.
Where is Citius Pharmaceuticals headquartered?
Citius Pharmaceuticals is headquartered in Cranford, US.